Clinical Trial Update: Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD [Phase 3]

View source ↗

Summary

A Phase 3 long-term open-label safety study of pramipexole extended-release in patients with advanced Parkinson disease was conducted; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pramipexole ER (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-07-14